Development of Multi-Pathogen Vaccines: Current Advances and Challenges  

Jessi J. White
Author    Correspondence author
Journal of Vaccine Research, 2024, Vol. 14, No.   
Received: 01 Jan., 1970    Accepted: 01 Jan., 1970    Published: 11 Oct., 2024
© 2024 BioPublisher Publishing Platform
Abstract
Abstract This study explores the current progress in the development of multipathogen vaccines, with a focus on innovative approaches and emerging technologies driving advancements in this field. Developments include the use of novel vaccine platforms such as mRNA technology, viral vectors, and nanoparticle-based systems, which have made it possible to create vaccines that effectively target multiple pathogens. However, significant challenges remain, including addressing antigenic interference, ensuring balanced immune responses, and overcoming production and regulatory hurdles. The study also discusses the importance of collaborative efforts and public-private partnerships in advancing multipathogen vaccines, highlighting unmet needs within the field. By analyzing successful and unsuccessful cases of existing and candidate vaccines, this research provides a comprehensive overview of the potential and obstacles in multipathogen vaccine development and discusses their implications for future global health initiatives. Keywords Multi-pathogen vaccines; Vaccine development; mRNA technology; Antigen design; Vaccine manufacturing; Immunology
Keywords

(The advance publishing of the abstract of this manuscript does not mean final published, the end result whether or not published will depend on the comments of peer reviewers and decision of our editorial board.)
The complete article is available as a Provisional PDF if requested. The fully formatted PDF and HTML versions are in production.
Journal of Vaccine Research
• Volume 14
View Options
. PDF
Associated material
. Readers' comments
Other articles by authors
. Jessi J. White
Related articles
Tools
. Post a comment